H.Res. 960

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 960 Introduced in House (IH)]

<DOC>

119th CONGRESS
1st Session
H. RES. 960

Expressing support for the designation of November 2025 as ``National 
Lung Cancer Awareness Month'' and expressing support for early 
detection and treatment of lung cancer.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

December 18, 2025

Mr. Boyle of Pennsylvania (for himself and Mr. Lawler) submitted the 
following resolution; which was referred to the Committee on Energy and 
Commerce

_______________________________________________________________________

RESOLUTION

Expressing support for the designation of November 2025 as ``National 
Lung Cancer Awareness Month'' and expressing support for early 
detection and treatment of lung cancer.

Whereas lung cancer is the leading cause of cancer-related death among 
individuals in the United States, accounting for more deaths than 
colorectal, breast, and prostate cancer combined;
Whereas, in 2025, an estimated 226,650 individuals in the United States will be 
diagnosed with lung cancer, and 124,730 individuals (approximately 340 
individuals per day) will die from the disease;
Whereas 1 in 16 men and 1 in 17 women in the United States will develop lung 
cancer during their lifetimes;
Whereas each year more women die from lung cancer than breast, ovarian, and 
cervical cancer combined;
Whereas, in 2025, cigarette smoking directly caused approximately 109,100 of the 
124,730 lung cancer deaths, and exposure to secondhand smoke causes over 
7,300 lung cancer deaths each year in adults who do not smoke;
Whereas approximately 10 to 20 percent of lung cancer diagnoses occur in people 
who have never smoked, and the proportion of lung cancer diagnoses in 
individuals who have never smoked is increasing in the United States;
Whereas women who never smoked are more likely than men who never smoked to get 
lung cancer;
Whereas Black men have the highest incidence of lung cancer and the highest 
mortality rate from lung cancer in the United States, and nonwhite 
individuals are 13 to 18 percent less likely to be diagnosed with lung 
cancer early in their lives;
Whereas veterans are 25 percent more likely to develop lung cancer compared to 
the general public, and although approximately 1,000,000 to 2,000,000 
veterans have an elevated risk of lung cancer and are eligible for 
screening, less than 3 percent of veterans get screened;
Whereas lung cancer is the second most commonly diagnosed cancer in veterans;
Whereas the 5-year survival rate is 67 percent for those diagnosed with 
localized lung cancer and 12 percent for those diagnosed at a stage when 
the cancer has spread to distant parts of the body;
Whereas the number of individuals in the United States recommended to receive 
lung cancer screening was estimated to be 14,500,000 as of 2021;
Whereas only 16 percent of individuals in the United States at high risk for 
lung cancer undergo lung cancer screening;
Whereas limited geographic availability of facilities and transportation 
barriers are persistent challenges to lung cancer screening;
Whereas 62 percent of adults are not familiar with lung cancer screening and the 
low-dose computed tomography scan;
Whereas the stigma surrounding lung cancer--

(1) creates barriers to early diagnosis, treatment, and research; and

(2) has a detrimental impact on the quality of life of lung cancer 
patients;

Whereas lung cancer research is leading to breakthroughs in biomarker 
identification and the development of immunotherapies and targeted 
therapies that are improving survival and quality of life for those with 
lung cancer;
Whereas access to biomarker testing and cutting-edge diagnostics is challenging 
across populations and geographic areas; and
Whereas educational efforts can increase awareness of lung cancer and lung 
cancer screening among the general public, patients and their families, 
and health care workers and increase the early detection of lung cancer: 
Now, therefore, be it
Resolved, That the House of Representatives--
(1) supports the designation of ``National Lung Cancer 
Awareness Month'';
(2) supports the designation of ``National Women's Lung 
Cancer Awareness Week'';
(3) supports the designation of ``National Lung Cancer 
Screening Day'';
(4) supports the purposes and ideals of National Lung 
Cancer Awareness Month;
(5) promotes efforts to increase awareness of, education 
about, and research on--
(A) mitigation of risk factors for lung cancer;
(B) lung cancer screening;
(C) treatment of lung cancer; and
(D) lung cancer affecting minorities and 
individuals who have never smoked; and
(6) encourages the people of the United States to observe 
National Lung Cancer Awareness Month with appropriate awareness 
and educational activities.
<all>